Arcutis Biotherapeutics, Inc. SEC filings ARQT

Arcutis Biotherapeutics, Inc. has 866 filings in SEC EDGAR's recent list, going back to Sep 9, 2019. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Apr 21, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 21, 2026 Apr 21, 2026
10-K Annual report Feb 25, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 29, 2025 Apr 28, 2025
10-K Annual report Feb 25, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 26, 2024 Apr 26, 2024
10-K Annual report Feb 27, 2024 Dec 31, 2023
10-K/A Amended annual report Sep 15, 2023 Dec 31, 2022
10-K Annual report Feb 28, 2023 Dec 31, 2022
10-K/A Amended annual report Mar 3, 2022 Dec 31, 2021
10-K Annual report Feb 22, 2022 Dec 31, 2021
10-K Annual report Feb 16, 2021 Dec 31, 2020
10-K Annual report Mar 19, 2020 Dec 31, 2019

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ARQT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Westlake Village, CA
SEC filer status
Large accelerated filer
SEC CIK
1787306
Former names
Arcutis, Inc. (until Sep 9, 2019)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.